N. Gervasoni

发表

Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode

N. Gervasoni, J. Aubry, G. Bondolfi, 2005, Neuropsychobiology.

Early telephone intervention for psychiatric outpatients starting antidepressant treatment

N. Gervasoni, J. Aubry, G. Bondolfi, 2010, Nordic journal of psychiatry.

The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.

N. Gervasoni, J. Aubry, G. Bondolfi, 2007, Journal of psychiatric research.

Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.

J. Golaz, N. Gervasoni, J. Aubry, 2004, Journal of psychiatric research.

Arguments in favour of : “ Family and couple therapies / Systemic therapies ”

N. Gervasoni, Philip Nielsen, M. Bischoff, 2010 .

Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?

N. Gervasoni, J. Aubry, G. Bondolfi, 2009, Pharmacological research.

Phenomenology of mixed states: a principal component analysis study.

N. Gervasoni, J. Aubry, G. Bertschy, 2007, Bipolar disorders.

A catatonic syndrome in a postpartum major depressive episode with psychotic features

N. Gervasoni, J. Aubry, 2008 .

Frequency of Dysphoria and Mixed States

N. Gervasoni, J. Aubry, G. Bertschy, 2008, Psychopathology.

CYP2D6 and ABCB1 Genetic Variability: Influence on Paroxetine Plasma Level and Therapeutic Response

C. Eap, N. Gervasoni, J. Aubry, 2008, Therapeutic drug monitoring.

Time course of response to paroxetine: Influence of plasma level

C. Eap, N. Gervasoni, J. Aubry, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Pharmacogenetic Study on Risperidone Long-Acting Injection: Influence of Cytochrome P450 2D6 and Pregnane X Receptor on Risperidone Exposure and Drug-Induced Side-Effects

C. Eap, N. Gervasoni, G. Bondolfi, 2013, Journal of clinical psychopharmacology.

Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity

N. Gervasoni, J. Aubry, G. Bondolfi, 2005, Biological Psychiatry.

Self-rated residual symptoms do not predict 1-year recurrence of depression

N. Gervasoni, J. Aubry, G. Bondolfi, 2010, European Psychiatry.

A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study.

J. Golaz, N. Gervasoni, J. Aubry, 2006, Swiss medical weekly.

Subjective Experience of Thought Overactivation in Mood Disorders: Beyond Racing and Crowded Thoughts

N. Gervasoni, J. Aubry, G. Bertschy, 2013, Psychopathology.

Performance of the Mood Disorder Questionnaire (MDQ) according to bipolar subtype and symptom severity

N. Gervasoni, J. Aubry, G. Bondolfi, 2009, European Psychiatry.

Screening for bipolar disorders using a French version of the Mood Disorder Questionnaire (MDQ).

N. Gervasoni, J. Aubry, G. Bondolfi, 2005, Journal of affective disorders.

The cortisol awakening response in patients remitted from depression.

M. Van der Linden, N. Gervasoni, J. Aubry, 2010, Journal of psychiatric research.

CYP2D6 and ABCB1 Genetic Variability: Influence on Paroxetine Plasma Level and Therapeutic Response

C. Eap, N. Gervasoni, J. Aubry, 2008, Therapeutic drug monitoring.

Trends in psychiatry

N. Gervasoni, J. Aubry, G. Bertschy, 2008, Psychiatric Quarterly.